SEC Form D private-offering filing

SightStream Biotherapeutics, Inc.

Name: SightStream Biotherapeutics, Inc. - new SEC Form D private-offering filing, Walpole, MA
Published: 2025-10-16

A new SEC Form D private-offering notice from Walpole, MA, a $1,791,165 filer-stated offering target in Biotech. The source filing is one click away.

SightStream Biotherapeutics, Inc. site↗ Verified via SEC Form D

Biotech spun out of Harvard developing eye drop therapies for corneal endothelial cell loss, formerly known as Kera Therapeutics

Filed 2025-10-16Filed to raise $1,791,165First money in 2025-10-02Raised so far $1,791,165HQ (as filed) Walpole, MASector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified sightstreambio.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.